Tirzepatide: Revolutionizing Youth-Onset Type 2 Diabetes Management

Created using ChatSlide

This research examines the safety and efficacy of Tirzepatide in treating youth-onset type 2 diabetes. Conducted as a phase 3, randomized, double-blind trial, it involved 99 participants aged 10 to less than 18 years, with control management via Metformin and Insulin. Primary outcomes focused on HbA1c levels, while secondary outcomes included BMI reduction and lipid profile improvements. Results demonstrated significant HbA1c and fasting serum glucose reduction, emphasizing Tirzepatide’s...